PF-Atlas › Clinical Trials › NCT02750722
Exercise and Oscillatory Positive Expiratory Pressure Therapy in Cystic Fibrosis
Flutter® · Not specified
Registry ID
NCT02750722
Phase
Not specified
Status
Completed
Drug / intervention
Flutter®
Sponsor
University of Zurich
Start
2016-05
Enrollment
16
Locations
3
About this trial
The investigators aim to compare a single bout of moderately intense cycling exercise incorporating Flutter® breathing maneuvers with a single bout of moderately intense cycling exercise alone on sputum viscoelasticity (primary endpoint) and the diffusion capacity of the lungs in adult patients with cystic fibrosis. The investigators further aim to analyze the short-term variability of resting diffusion capacity of carbon monoxide (DLCO) and nitric oxide (DLNO) in patients with cystic fibrosis.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT02750722 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.